Navigation Links
Moffitt Cancer Center researchers find men less willing to be screened for cancer

TAMPA, Fla. -- Although men have higher cancer mortality rates than women, they are less willing to be screened for cancer, according to a study conducted by researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues at Sanoa Consulting LLC, Muscle Shoals, Ala., and the New York University College of Dentistry.

The study, which was funded by the National Institute of Dental and Craniofacial Research/National Institutes of Health, was conducted in New York City, Baltimore, Maryland and San Juan, Puerto Rico, through a random-dial telephone survey of 1,148 adult African Americans, whites, and Puerto Rican Hispanics who answered questions from the Cancer Screening Questionnaire. The majority of those surveyed were 30 to 59 years of age. The study has been released online and will be published in an upcoming issue of the American Journal of Men's Health.

"This study examined beliefs and attitudes held by men and women about cancer screening," said study corresponding author Jenna L. Davis, M.P.H., of Moffitt's Department of Health Outcomes and Behavior. "Our aim was to gain insight for improving existing cancer health promotion practices. Our findings indicate that there is a need for better health and cancer screening promotion among men."

The researchers suggested that the screening participation gap between men (who accounted for 35 percent of those surveyed) and women may be related to several factors. For example, more cancer awareness promotions in the media are aimed at women's breast cancer; there is a lack of government sponsored men's cancer awareness campaigns; and studies indicate that women visit their primary care doctors more often than do men.

According to co-author B. Lee Green, Ph.D., Moffitt senior member and the vice president of Moffitt Diversity, there is far less coverage in the media of men's cancers. For example, the authors cite a previous study showing that mammography is more often mentioned in newspaper articles than the prostate specific antigen (PSA), the screening tool for prostate cancer.

"There are many fundraisers, commercials and community awareness events about women's cancers, such as breast cancer," said Green. "For example, the National Football League allows players to wear pink during October Breast Cancer Awareness Month. The Prostate Cancer Foundation has only recently petitioned the NFL to recognize National Prostate Cancer Awareness Month by allowing players to wear blue in September."

The authors also note that within national government agencies, men's health promotions are lacking. While the National Institutes of Health has an Office of Research on Women's Health, there is no such office for men's health.

Another variable may be that women are more frequent consumers of health care.

"Women generally have more ongoing and routine visits to their primary care doctors than men," said Davis. "They are more likely to be screened during these visits."

The study concluded that when men are provided with the details of screening procedures who conducts the screening, what men have to do men were slightly more likely to participate in cancer screening than women.

"This strongly suggests that men will participate in screening when given more information about screening procedures," concluded Davis. "This means that health educators, physicians and community-based organizations should make a concerted effort to educate men on exact screening procedures, explain how cancer is detected, and communicate what to expect during screening."

Contact: Ferdie De Vega
H. Lee Moffitt Cancer Center & Research Institute

Related medicine news :

1. Moffitt Cancer Center and GLG Pharma, LLC sign licensing agreement to develop the next generation of targeted anti-cancer therapeutics
2. Moffitt Cancer Center and GLG Pharma LLC sign licensing agreement to develop the next generation of targeted anti-cancer therapeutics
3. Moffitt Cancer Center researchers use new tool to counter multiple myeloma drug resistance
4. Moffitt researchers find possible key to preventing chemotherapy resistance in ovarian cancer
5. Moffitt Cancer Center researchers find more clues to causes of breast cancer
6. Moffitt Cancer Center researchers find regulatory T-cell clue to help prevent GVHD
7. Moffitt Cancer Center researchers unravel biochemical factor important in tumor metastasis
8. Enhancing arrest of cell growth to treat cancer in mice
9. Paxil Blocks Tamoxifen, Lowers Survival Odds Against Breast Cancer
10. The National Coalition for Cancer Survivorship Joins the Commission on Cancer
11. Low forms of cyclin E reduce breast cancer drugs effectiveness
Post Your Comments:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned by ... to enhance the health of felines. The formula is all-natural and is made from ... the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Research and Markets has announced the addition ... - Forecast to 2022" report to their offering. ... to date financial data derived from varied research sources to ... potential impact on the market during the next five years, ... of sub markets, regional and country level analysis. The report ...
(Date:6/23/2016)... , June 23, 2016 Bracket , ... launch its next generation clinical outcomes platform, Bracket eCOA (SM) ... held on June 26 – 30, 2016 in ... first electronic Clinical Outcome Assessment product of its kind to ... #715. Bracket eCOA 6.0 is a flexible platform ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas ... Brasil as the company,s second affiliate in Latin America . ... ... of Astellas Farma Colombia ... ...
Breaking Medicine Technology: